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Research Paper
Utility of surgeon-performed
pre-operative ultrasound in the
localisation of parathyroid adenomas
Paul RS Thomas1, Andrew D Beggs2,3 and Thang S Han4,5
Abstract
Background: Primary hyperparathyroidism arising from parathyroid adenoma is one of the most common
endocrine disorders treated by endocrine surgeons. The adenoma is commonly identified by imaging techniques.
The present study evaluated the performance of a portable ultrasound machine (Sonosite MicroMaxx) operated by a
surgeon, departmental ultrasound and 99mTc-sestamibi-SPECT/CT by a radiologist in the identification of parathy-
roid adenomas.
Methods: Patient case notes were retrieved from medical records and imaging from picture archiving and communi-
cation system over the period from 2006 to 2012. 99mTc-sestamibi-SPECT/CT and departmental ultrasound images
were reported by a nuclear radiologist. The ability of each imaging technique in localising parathyroid adenomas was
referenced against the actual adenomas identified from parathyroidectomy.
Results: With reference to the actual site of the lesion, surgeon-performed ultrasound accurately localised the site of
the lesion in 30/33 (90.1%) of cases with a sensitivity of 86.7%, departmental ultrasound accurately localised the site of
the lesion in 21/26 (80.1%) of cases with a sensitivity of 79.2%. In 6/75 patients where 99mTc-sestamibi-SPECT/CT did
not localise the lesion, departmental ultrasound did not localise any lesions correctly, while surgeon-performed ultra-
sound successfully located the adenoma in three (50%) of these six patients. Patients whose parathyroid adenomas
identified by the surgeon were more likely to have shorter length of stay in hospital: odds ratio¼ 0.53 (95% confidence
interval¼ 0.30–0.92, p¼ 0.025).
Conclusions: Surgeon-performed ultrasound for immediately pre-operative localisation improves identification of
parathyroid adenomas and reduces length of stay in hospital, lending support for the use of this technique by endocrine
surgeons.
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Introduction
Primary hyperparathyroidism, caused by a parathyroid
adenoma secreting excessive amounts of parathyroid
hormone (PTH), and thus hypercalcaemia, is one of
the most common endocrine disorders seen by endo-
crine surgeons.1 The estimated incidence of primary
hyperparathyroidism is between 1 in 500 and 1 in
2000 people.2 The underlying pathophysiology of the
development of parathyroid adenomas remains unclear
but certain genetic syndromes, such as multiple endo-
crine neoplasia type 1 and type 2 can cause primary
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hyperparathyroidism due to either parathyroid hyper-
plasia or a parathyroid adenoma.3
Conventional surgical techniques for excision and
removal of parathyroid adenomas have relied on neck
dissection,4 identification of all parathyroid glands and
removal of those that appear to be adenomatous. This
can be facilitated by the use of peri-operative frozen
section to identify whether removed tissue is a parathy-
roid adenoma in cases of uncertainty. However, this
can lead to over-enthusiastic removal of normal para-
thyroid tissue and consequential hypocalcaemia that
requires lifelong treatment. This has led surgeons to
search for methods that can precisely localise parathy-
roid tissue and consequently reduce the size of the neck
incision leading to better cosmesis, reduced operative
time and complications as well as improved patient
satisfaction.5
Multiple pre-operative and peri-operative techni-
ques have been used for identification of the presence
and location of abnormal parathyroid tissue. Pre-
operative investigations usually take the form of radio-
logical investigations, and the three most common
investigations are, in the order of utilisation, 99mTc-
sestamibi scintigraphy,6 neck ultrasound7 and
11C-methionine positron emission tomography.8
Combining 99mTc-sestamibi scintigraphy with single-
photon emission computerised tomography (SPECT)
camera and fused with computed tomography (CT)
(99mTc-sestamibi SPECT/CT) increases the accuracy
in anatomical localisation of parathyroid adenomas.
Potential drawbacks with this system include the use
of radioisotopes, slow scan time, poor anatomical
localisation in the case of two glands in close proximity
with each other and lack of availability of nuclear med-
icine departments in many hospitals.
This has led to the use of high-frequency ultrasound
examination of the neck to identify parathyroid adeno-
mas in B-mode images. Parathyroid adenomas can be
seen as hypoechoic lesions situated posterior and either
superior or inferior to the poles of the thyroid gland.
Ultrasound has a number of advantages including the
avoidance of ionising radiation, readily available in
every hospital and accuracy in anatomical localisation.
A solution to the issue described above is to use of
99mTc-sestamibi SPECT/CT pre-operatively in all
patients with peri-operative localisation of the parathy-
roid gland employing high-frequency ultrasound using
a portable ultrasound machine.9 This allows precise
localisation based on two imaging modalities as well
as highly precise placement of the incision by the sur-
geon, minimising its size and reducing duration of
operation. We have been performing this intervention
since 2005 which enables us to perform a minimally
invasive parathyroidectomy (MIP) and early discharge
(within 23 h) in most patients.
In this study, we evaluated the performance of six
years of a portable ultrasound machine operated by a
surgeon compared to that by 99mTc-sestamibi-SPECT/
CT or by ultrasound performed by a consultant
radiologist.
Methods
Patients were reviewed retrospectively over the period
from 2006 to 2012 as part of clinical audit. All patient
case notes were retrieved from medical records and
imaging from the picture archiving and communication
system. All imaging was performed using standardised
techniques. 99mTc-sestamibi scintigraphy utilises the
gamma-emitting isotope Technicium-99m bound to
the ligand methoxyisobutylisonitrile (MIBI) which is
avidly taken up by the prolific oxyphil cells of parathy-
roid adenomas. Planar and SPECT images, acquired
with static views of the neck and thorax to include
the mediastinum, were taken at 10, 20 and 120 min.
Reconstruction and co-registration planar images
were taken with a CT scan and performed at the
same visit.
Images were examined and reported by a consultant
radiologist with an expertise in nuclear medicine. The
diagnosis of parathyroid adenomas was based on early
and delayed imaging and SPECT/CT to determine
asymmetric foci of uptake in the thyroid bed region.
Technicium-99m bound MIBI is taken up both by thy-
roid and parathyroid glands, but has a slower washout
from the parathyroid, so on the later images the para-
thyroid becomes relatively more prominent than the
thyroid, particularly the adenomas.
Departmental ultrasound was performed by the
same consultant radiologist. Surgeon-performed ultra-
sound was carried out by a single operator (PRST)
employing a portable ultrasound machine (Sonosite
MicroMaxx, Soma Technology, Inc., Bloomfield, CT,
USA) using a 5–10 MHz linear array transducer.
Imaging was performed immediately prior to skin prep-
aration with the patient positioned supine on the oper-
ating table, with a sand bag between the shoulder
blades, the neck extended and head rested on a head
ring. The neck was imaged both in the transverse and
cranio-caudal plane to visualise parathyroid glands.
Site of parathyroid gland was recorded for 99mTc-
sestamibi-SPECT/CT, departmental ultrasound scan
and surgeon-performed ultrasound. If the adenoma
was localised easily, an MIP was carried out. If the
adenoma could not be visualised, or if at MIP the ade-
noma could not be found, an open exploration was
performed. Frozen section was not routinely performed
unless there was uncertainty about the diagnosis. All
patients had 99mTc-sestamibi-SPECT/CT investiga-
tions and a proportion of these patients received
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additional ultrasound scan performed by a radiologist
or by an endocrine surgeon; therefore, the number of
patients receiving ultrasound scan were smaller than
those by 99mTc-sestamibi-SPECT/CT.
Histology reports were obtained from the electronic
patient record (EPR) computer system and site of para-
thyroid gland and histology recorded. In the case of
multiple parathyroid glands removed, all sites were
recorded. Patients had serum PTH and Ca2þ measured
six weeks after the operation, and the gland was said to
have been successfully removed if serum Ca2þ/PTH
levels were normalised.
Statistical analysis
Associations between investigative methods with the
actual site of the lesion identified surgically (reference
method) were assessed by Lin’s correlation coefficient
and accuracy of methods was tested by sensitivity and
specificity. Logistic regression was conducted to (1)
assess patient characteristics (age, sex, pre-operative
Ca2þ and PTH levels and position of the parathyroid
adenoma) that may influence the detection of parathy-
roid lesions and (2) examine the association of post-
operative length of stay in hospital with parathyroid
adenoma identified by surgeon-performed ultrasound,
departmental ultrasound and by 99mTc-sestamibi-
SPECT/CT. Analyses were conducted using STATA
(StataCorp., 2015, Stata Statistical Software: Release
14, StataCorp LP, College Station, TX, US). The null
hypothesis was rejected when p< 0.05.
Results
In the period January 2006–January 2011 a total of 75
patients (21 men and 54 women) underwent surgical
neck exploration and parathyroidectomy. The median
age of patients was 63 years (range 26–87). The median
pre-operative calcium levels were 2.66mmol/l (inter-
quartile range¼ 2.53–2.79) and post-operative levels
were 2.40mmol/l (interquartile range¼ 2.24–2.45).
The pre-operative PTH levels were 26.4 pmol/l (inter-
quartile range¼ 14.5–72.85). Median length of stay in
hospital was one day (interquartile range¼ 1–2 days)
with 9/75 (12%) patients undergoing day-case
parathyroidectomy.
A parathyroid adenoma lying posterior to the infe-
rior pole of the left lobe of thyroid of a woman was
identified by ultrasound scan (Figure 1) and by early
and delayed phases of SPECT (Figure 2(a)) which is
confirmed by fused 99mTc-sestamibi-SPECT/CT images
(Figure 2(c) and (d)). Table 1 shows that 99mTc-sesta-
mibi-SPECT/CT correctly identified 74% of those with
parathyroid adenoma, while surgeon-performed ultra-
sound improved the identification further to 91%.
Both techniques had similar false positive rates.
Department-performed ultrasound by a radiologist cor-
rectly identified 80% of those with parathyroid adeno-
ma while incorrectly identified 15.4% of those without
parathyroid adenoma as positive result. Surgeon-
operated ultrasound did not result in any negative find-
ing when the adenoma was present, while about 4% of
patients with an adenoma were found to be negative by
99mTc-sestamibi-SPECT/CT or radiologist.
Table 2 shows that based on the data from 99mTc-
sestamibi-SPECT/CT investigation, the majority of
parathyroid adenomas were located inferiorly (46.5%
right inferior and 38.0% left inferior) and more to the
right (46.5% right inferior and 4.2% left inferior) than
left (38.0% left inferior and 11.3% left superior) thy-
roid lobe. These numbers similarly occurred in ultra-
sound investigations.
The correlation between the actual site of the para-
thyroid adenoma identified by surgery and the site of the
adenoma identified by 99mTc-sestamibi-SPECT/CT was
0.79 (95% confidence interval (CI)¼ 0.70–0.88), by
surgeon-performed ultrasound was 0.87 (0.77–0.96)
and by departmental ultrasound was 0.58 (0.30–0.85).
99mTc-sestamibi-SPECT/CT accurately localised the
site of the lesion in 61/75 (81.3%) of cases with a sensi-
tivity of 81.3%, while surgeon-performed ultrasound
accurately localised the site of the lesion in 30/33
(90.1%) of cases with a sensitivity of 86.7% and the
corresponding values for departmental-performed ultra-
sound were 21/26 (80.1%) and 79.2%, respectively.
In cases where 99mTc-sestamibi-SPECT/CT did not
localise the lesion (6 out of 75 patients), surgeon-
performed ultrasound correctly located the abnormal
gland in three of them (50%). Departmental ultra-
sound did not identify any lesions that were not seen
on 99mTc-sestamibi-SPECT/CT.
Figure 1. Parathyroid adenoma lying posterior to the inferior
pole of left lobe of thyroid identified by ultrasound scan in
a woman.
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Univariable logistic regression (Table 3) showed that
the age, pre-operative Ca2þ and PTH levels, sex and
position of the lesion did not influence the identifica-
tion of parathyroid adenoma by any of the three
techniques. Patients whose parathyroid adenomas
identified by the surgeon were more likely to have
shorter length of stay in hospital: unadjusted odds
ratio (OR)¼ 0.54 (95% CI¼ 0.30–0.995, p¼ 0.035).
Figure 2. Anterior maximum intensity projection images from early (15 min) and delayed (2 h) phases of SPECT in the same woman
undergoing ultrasound scan (Figure 1) showing delayed washout of radiotracer in the left inferior parathyroid adenoma (a). Delayed-
phase coronal (b), sagittal (c) and axial (d) fused 99mTc-sestamibi-SPECT/CT images confirm this parathyroid adenoma localising
posterior to the inferior pole of the left lobe of thyroid (c,d).
Table 1. Accuracy in the identification of parathyroid adenoma performed by different techniques.
99mTc-sestamibi-SPECT/CT Surgeon-performed ultrasound Department-performed ultrasound
n¼ 74 n¼ 33 n¼ 26
True positives 61 (74.0%) 30 (90.9%) 21 (80.8%)
False positives 10 (8.2%) 3 (9.1%) 4 (15.4%)
False negatives 3 (4.1%) 0 1 (3.8%)
True negatives 0 0 0
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This association continued to persist after confounding
factors (age, sex, Ca2þ and PTH levels and site of para-
thyroid adenoma) were accounted for using multivari-
able model: adjusted OR¼ 0.53 (95% CI¼ 0.30–
0.92, p¼ 0.025).
Discussion
We have demonstrated that surgeon-performed ultra-
sound in the immediate pre-operative period provides
additional identification of cases where 99mTc-sesta-
mibi-SPECT/CT and departmental ultrasound did
not localise the lesion. Patients whose parathyroid ade-
nomas identified by surgeon were more likely to have
shorter length of stay in hospital.
Findings of localisation of parathyroid adenoma by
surgeon in our study are similar to those reported from
previous studies. Soon et al.10 studied 87 cases and
showed that peri-operative scan correctly localised
83% of patients, while the larger study by Untch
Table 2. Comparison of site of lesion with scanning results for 99mTc-sestamibi-SPECT/CT, surgeon-performed ultrasound and
department-performed ultrasound.
Site of lesion
Left superior Right superior Left inferior Right inferior Total
99mTc-sestamibi-SPECT/CT
Left superior 5 (7.0) 0 1 (1.4%) 0 6 (8.5%)
Right superior 0 2 (2.8%) 2 (2.8%) 2 (2.8%) 6 (8.5%)
Left inferior 3 (4.2) 0 23 (32.4) 0 26 (36.6%)
Right inferior 0 1 (1.4%) 1 (1.4%) 31 (43.7) 33 (46.5%)
Total 8 (11.3%) 3 (4.2%) 27 (38.0%) 33 (46.5%) 71 (100%)
Surgeon-performed ultrasound
Left superior 2 (6.1%) 0 0 0 2 (6.1%)
Right superior 1 (3.0%) 2 (6.1%) 1 (3.0%) 1 (3.0%) 5 (15.2%)
Left inferior 0 0 10 (30.3%) 0 10 (30.3%)
Right inferior 0 0 1 (3.0%) 15 (45.5%) 16 (48.5%)
Total 3 (9.1%) 2 (6.1%) 12 (36.4%) 16 (48.5%) 33 (100%)
Department-performed ultrasound
Left superior 2 (8.0%) 0 0 0 2 (8.0%)
Right superior 0 3 (12.0%) 1 (4.0%) 1 (4.0%) 5 (20.0%)
Left inferior 0 0 8 (32.0%) 1 (4.0%) 9 (36.0%)
Right inferior 1 (4.0%) 0 0 8 (32.0%) 9 (36.0%)
Total 3 (12.0%) 3 (12.0%) 9 (36.0%) 10 (40.0%) 25 (100%)
Table 3. Table of odds ratios, 95% confidence intervals and p-values for surgeon-performed ultrasound, department-performed
ultrasound and 99mTc-sestamibi-SPECT/CT as determined by univariate logistic regression analysis.
Surgeon-performed
ultrasound
Department-performed
ultrasound 99mTc-sestamibi-SPECT/CT
Variable OR (95% CI) p OR (95% CI) p OR (95% CI) p
Length of stay in hospital 0.54 (0.30–0.96) 0.035 1.01 (0.68–1.51) 0.959 1.58 (0.50–4.92) 0.434
Pre-operative Caþþ 0.32 (0.02–4.15) 0.383 0.72 (0.06–8.22) 0.791 1.04 (0.03–39.0) 0.982
Post-operative Caþþ 9.40 (0.13–651) 0.300 9.57 (0.20–452) 0.251 0.50 (0.01–164) 0.814
PTH 0.98 (0.97–1.01) 0.167 0.99 (0.98–1.01) 0.898 1.01 (0.98–1.04) 0.514
Female (referent) 1 1
Male 0.22 (0.04–1.24) 0.087 0.44 (0.09–2.07) 0.297 1.31 (0.12–14.1) 0.825
Age 1.02 (0.97–1.07) 0.491 1.01 (0.97–1.06) 0.617 1.01 (0.94–1.09) 0.770
Left superior adenoma (referent) 1 – 1 – 1 –
Right superior adenoma 0.77 (0.02–27.6) 0.886 –a – 0.02 (0.01–1.99) 0.089
Left inferior adenoma 1.40 (0.12–16.9) 0.788 1.18 (0.14–10.2) 0.881 0.48 (0.05–4.32) 0.514
Right inferior adenoma 0.42 (0.04–4.61) 0.478 0.78 (0.09–6.85) 0.819 1.24 (0.46–3.31) 0.666
PTH: parathyroid hormone; OR: odds ratio; CI: confidence interval.
aNot enough data for analysis. Significant results are shown in bold.
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et al.11 of 392 showed that scan in clinic setting correct-
ly localised 87% of patients. Other studies have found
similar results including those by van Ginhoven et al.12
with reported accuracy of 85%. Solorzano et al.13
reported an accuracy of 67% in patients with non-
localising 99mTc-sestamibi scans and Steward et al.14
reported a sensitivity of 87% by surgeon-performed
scan and 58% by 99mTc-sestamibi. In a UK-based
study, Aspinall et al.15 found that surgeon-performed
ultrasound had an accuracy of 86% in detecting the
position of parathyroid adenomas in outpatient clinics.
It should be borne in mind that apart from its value in
localising primary parathyroid adenomas, 99mTc-sesta-
mibi-SPECT/CT is vital for identifying major parathy-
roid ectopias16 and parathyroid glands in secondary
hyperparathyroidism.17,18 The present study found
none of the patient had evidence of ectopic parathyroid
glands.
There is considerable variability in the detection
rates of adenomas when department ultrasound is per-
formed by a radiologist. Sensitivity of 80.1% in our
study is relatively higher than in other previously
reported findings. Ultrasound scan technique is opera-
tor dependent but surgeons appears to perform better
than radiologist which could be explained by factors
such as experience of the surgeon who specialises in
this area of expertise. Caution should be taken when
interpreting our findings and should not be generalised
to other populations since this study was conducted in
a single centre and carried out by a single operator. Our
surgeon operator (PRST) had a 100% repeatability
record for ultrasound identification of parathyroid ade-
nomas. We did not examine inter-observer variability
for any of the modalities in the present study but a
review by Wong et al.16 reported an inter-observer
agreement of SPECT/CT to be high (j value¼ 0.91).
Another issue surrounds that of training; whereas
training is available for surgeons to learn parathyroid
ultrasonography in the US,19 there exists no such
formal training programmes in the UK. Based on our
findings and existing published results, formal training
in parathyroid ultrasonography in the UK for surgeons
specialising in parathyroid surgery would help improve
standards in the identification of parathyroid adeno-
mas. By necessity, a capital outlay associated with the
set-up of this type of service would lead to savings in
costs in terms of reduced negative exploration rates,
more rapid recovery and reduction in use of unneces-
sary investigations.
The present study has its limitations in that the
groups of patients examined by the three techniques
were not the same; therefore, there might have been
some differences in complexity of the patients’ condi-
tion. However, we found patient characteristics includ-
ing age, Ca2þ and PTH levels, and sex did not influence
the ability to locate abnormal parathyroid gland, with
the exception of post-operative length of stay in hospi-
tal which was shorter for those whose parathyroid ade-
nomas were identified by the surgeon. Other limitations
from the present study include that certain patients did
not undergo assessment by all three modalities, which
is not ideal. However, this situation reflects clinical
practice rather than research investigation; when a
parathyroid adenoma is clearly identified by 99mTc-ses-
tamibi-SPECT/CT, with strong support from biochem-
ical investigations, it is justifiable not to subject patients
to undergo further investigations. In a clinical setting,
the surgeon also has access to previous results from
department ultrasound and 99mTc-sestamibi-SPECT/
CT (i.e. not blinded); therefore, there is a potential
bias in favour of the surgeon in the identification of
parathyroid adenomas.
Diagnostic criteria vary between centres which may
have some bearing on our findings. We employed the
commonly adopted technique based on delayed wash-
out of Technicium-99m bound MIBI to identify para-
thyroid adenomas, which is principally a qualitative
technique. Some authors have reported a semi-
quantitative approach, based on the certainty of
uptake foci, which is classified according to diagnostic
confidence score from 1 to 4 (1¼ definitely negative,
2¼doubtful but probably negative, 3¼ probably pos-
itive, 4¼positive). Scores of 3 and 4 meet diagnostic
criteria for parathyroid adenomas.20
In conclusion, findings from our study indicate
that surgeon-performed ultrasound for immediately
pre-operative localisation improves identification of
parathyroid adenomas and reduces length of stay in
hospital, lending support for the use of this technique
by endocrine surgeons.
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